Compound Summary
Compound Information
kenpaullone
Compound Name: | kenpaullone |
Compound CID: | 3820 |
Synonyms: | kenpaullone 142273-20-9 9-Bromopaullone NSC 664704 9-Bromo-7,12-dihydroindolo3,2-d1benzazepin-6(5H)-one More... |
Iupac Name: | 9-bromo-7,12-dihydro-5H-indolo[3,2-d][1]benzazepin-6-one |
InChI: | InChI=1S/C16H11BrN2O/c17-9-5-6-14-11(7-9)12-8-15(20)18-13-4-2-1-3-10(13)16(12)19-14/h1-7,19H,8H2,(H,18,20) |
InChIKey: | QQUXFYAWXPMDOE-UHFFFAOYSA-N |
Canonical Smiles: | C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)Br |
Isomeric Smiles: | C1C2=C(C3=CC=CC=C3NC1=O)NC4=C2C=C(C=C4)Br |
Molecular Weight: | 327.17 |
Molecular Formula: | C16H11BrN2O |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
kenpaullone
Molecular Weight: | 327.17 |
Molecular Formula: | C16H11BrN2O |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 20 |
Complexity: | 402 |
Synonyms
kenpaullone
| kenpaullone | kenpaullone |
|---|---|
kenpaullone |
142273-20-9 |
9-Bromopaullone |
NSC 664704 |
9-Bromo-7,12-dihydroindolo3,2-d1benzazepin-6(5H)-one |
NSC-664704 |
9-Bromopaullone;NSC-664704 |
NSC664704 |
9-bromo-7,12-dihydrobenzo2,3azepino4,5-bindol-6(5H)-one |
MLS002702152 |
CHEMBL296586 |
9-Bromo-7,12-dihydroindolo(3,2-d)(1)benzazepin-6(5H)-one |
Indolo3,2-d1benzazepin-6(5H)-one, 9-bromo-7,12-dihydro- |
MFCD02683595 |
9-bromo-7,12-dihydro-5H-indolo3,2-d1benzazepin-6-one |
9-Bromo-7,12-dihydro-indolo3,2-d1benzazepin-6(5H)-one |
SR-01000075952 |
Bromo Paullone |
Indolo3,2-d1benzazepin-6(5H)-one,9-bromo-7,12-dihydro- |
Paullone Analog 5 |
ACMC-20ddkx |
Kinome_3565 |
Tocris-1398 |
Kenpaullone, >=98% |
BiomolKI_000072 |
Lopac-K-3888 |
BiomolKI2_000076 |
NCIMech_000735 |
cid_3820 |
Lopac0_000647 |
SCHEMBL79889 |
cc-567 |
NSC-664704(Kenpaullone) |
BDBM7266 |
GTPL6000 |
STO175 |
CHEBI:92658 |
DTXSID10161994 |
EX-A702 |
BCPP000195 |
HMS3229K10 |
HMS3262A15 |
HMS3267F14 |
HMS3412M10 |
HMS3650F17 |
HMS3676M10 |
9-Bromo-7,12-dihydro-indolo-3,2-d-1benzazepin-6(5H)-one |
BCP02440 |
ZINC1639355 |
Tox21_500647 |
CCG-35778 |
CCG-36383 |
HSCI1_000038 |
s7917 |
AKOS024456573 |
BCP9000809 |
CS-5049 |
Indolo3, 9-bromo-7,12-dihydro-, |
LP00647 |
SDCCGSBI-0050627.P004 |
Kenpaullone - CAS 142273-20-9 |
SMP2_000306 |
NCGC00015582-01 |
NCGC00015582-02 |
NCGC00015582-03 |
NCGC00015582-04 |
NCGC00015582-05 |
NCGC00015582-06 |
NCGC00015582-18 |
NCGC00025143-01 |
NCGC00025143-02 |
NCGC00025143-03 |
NCGC00025143-04 |
NCGC00261332-01 |
AC-32896 |
AS-70762 |
HY-12302 |
NCI60_022295 |
SMR001456311 |
B6720 |
BB 0301260 |
EU-0100647 |
FT-0670607 |
K0052 |
X5716 |
F17055 |
K 3888 |
K00061 |
J-007630 |
J-521618 |
SR-01000075952-1 |
SR-01000075952-3 |
SR-01000075952-6 |
SR-01000075952-9 |
BRD-K37312348-001-04-4 |
BRD-K37312348-001-06-9 |
SR-01000075952-10 |
9-bromo-7,12-dihydroindolo3,2-d1-benzazepin-6(5h)-one |
8-Bromo-7,12-dihydro-indolo3,2-d1-benzazepin-6(5H)-one |
14-BROMO-8,18-DIAZATETRACYCLO9.7.0.0(2),?.0(1)(2),(1)?OCTADECA-1(11),2,4,6,12,14,16-HEPTAEN-9-ONE |
14-bromo-8,18-diazatetracyclo9.7.0.0;{2,7}.0;{12,17}octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one |
14-bromo-8,18-diazatetracyclo9.7.0.0^{2,7}.0^{12,17}octadeca-1(11),2,4,6,12,14,16-heptaen-9-one |
NSC-664704; 9-Bromo-7,12-dihydr9-Bromo-7,12-dihydroindolo3,2-d1benzazepin-6(5H)-one |
Experimental Data
kenpaullone
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 27 | S | N2 | 33683565 | Active | ||||||
| Caenorhabditis elegans | 88 | umol/L | 27 | S | N2 | 24134630 | Active |
Experimental Data Visualization
kenpaullone
Statistics Data
kenpaullone
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 27 | 2 | 2 |
Statistics Data Visualization
kenpaullone
